We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Virus filtration is a non-destructive, effective and easy-to-use method of retaining both enveloped and non-enveloped virus particles present on the surface or within the pores of a polymeric membrane. It is widely used in continuous bioprocessing, which is gaining traction in monoclonal antibodies (MAbs) for offering small facility footprints. As it does not impact the product quality, virus filtration is considered as a suitable solution for manufacturing biological products, such as vaccines, gene therapy, somatic cells and recombinant therapeutic proteins, and enhancing their safety. It is also utilized to eliminate blood-borne pathogens from plasma-derived products.
Get Sample Report with Detail COVID-19 Impact Analysis - https://www.imarcgroup.com/virus-filtration-market/requestsample
The increasing prevalence of chronic diseases and the urgent need for potential therapies and vaccines to treat coronavirus-affected patients are currently driving the global demand for virus filtrations. Furthermore, continuous advancements in bioprocessing technologies, including single-use equipment, perfusion reactors, and chromatography resins, are positively influencing the adoption of virus filtration in the production of various biotherapeutic products. Besides this, the introduction of an advanced asymmetric membrane structure that offers no impact on virus retention through pressure variations, high loads, or process interruptions is expected to strengthen the market growth over the forecasted period.
Explore Full Report with Detail Analysis with COVID-19 Impact –https://www.imarcgroup.com/virus-filtration-market
List of Key Companies Covered in this Market Report:
Asahi Kasei Medical Co. Ltd.
Charles River Laboratories, Inc (NYSE: CRL)
Danaher Corporation (NYSE: DHR)
Merck KGaA (ETR: MRK)
Sartorius AG (ETR: SRT)
Thermo Fisher Scientific Inc.(NYSE: TMO)
The report has segmented the market on the basis of product, application, end use and geography.
Breakup by Product:
Kits and Reagents
Breakup by Application:
Vaccines and Therapeutics
Blood and Blood Products
Cellular and Gene Therapy Products
Breakup by End Use:
Biopharmaceutical and Biotechnology Companies
Contract Research Organizations
Academic Institutes and Research Laboratories
Breakup by Geography:
North America (U.S. & Canada)
Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Others)
Asia Pacific (China, India, Japan, South Korea, Indonesia, Australia, and Others)
Latin America (Brazil, Mexico)
Middle East & Africa
Key highlights of the report:
Market Performance (2015-2020)
Market Outlook (2021- 2026)
Porter’s Five Forces Analysis
Market Drivers and Success Factors
Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Americas: +1-631-791-1145 | Europe & Africa: +44-753-713-2163 | Asia: +91-120-433-0800